{"id":"https://openalex.org/W2941631580","doi":"https://doi.org/10.1097/01.ju.0000556188.39522.b7","title":"PD31-03 PROPORTION OF WOMEN WITH OVERACTIVE BLADDER WHO PROGRESS FROM SECOND- TO THIRD-LINE TREATMENT IN A REAL-WORLD SETTING","display_name":"PD31-03 PROPORTION OF WOMEN WITH OVERACTIVE BLADDER WHO PROGRESS FROM SECOND- TO THIRD-LINE TREATMENT IN A REAL-WORLD SETTING","publication_year":2019,"publication_date":"2019-04-01","ids":{"openalex":"https://openalex.org/W2941631580","doi":"https://doi.org/10.1097/01.ju.0000556188.39522.b7","mag":"2941631580"},"language":"en","primary_location":{"id":"doi:10.1097/01.ju.0000556188.39522.b7","doi":"https://doi.org/10.1097/01.ju.0000556188.39522.b7","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ju.0000556188.39522.b7","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083981833","display_name":"Erika M. Wolff","orcid":"https://orcid.org/0000-0003-1160-374X","observed_orcids":["https://orcid.org/0000-0003-1160-374X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Erika Wolff*","raw_affiliation_strings":["Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle, WA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Thomas Cook","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Cook","raw_affiliation_strings":["Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle, WA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060486709","display_name":"Anna C. Kirby","orcid":"https://orcid.org/0000-0003-4653-4246","observed_orcids":["https://orcid.org/0000-0003-4653-4246"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Kirby","raw_affiliation_strings":["Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle, WA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003319562","display_name":"John L. Gore","orcid":"https://orcid.org/0000-0002-2847-5062","observed_orcids":["https://orcid.org/0000-0002-2847-5062"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Gore","raw_affiliation_strings":["Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle, WA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5083981833"],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.6406,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.69283432,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"201","issue":"Supplement 4","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10418","display_name":"Pelvic floor disorders treatments","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/overactive-bladder","display_name":"overactive bladder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/women","display_name":"women","score":0.7839999794960022},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.5899999737739563},{"id":"https://openalex.org/keywords/anticholinergic-drugs","display_name":"anticholinergic agents","score":0.45899999141693115},{"id":"https://openalex.org/keywords/antimuscarinic-agents","display_name":"antimuscarinic agents","score":0.49900001287460327},{"id":"https://openalex.org/keywords/antispasmodic-agents","display_name":"antispasmodic agents","score":0.4399999976158142},{"id":"https://openalex.org/keywords/real-world-prescribing-patterns","display_name":"real-world prescribing patterns","score":0.6679999828338623},{"id":"https://openalex.org/keywords/guideline-adherence","display_name":"guideline adherence","score":0.4519999921321869},{"id":"https://openalex.org/keywords/neuromodulation","display_name":"neuromodulation","score":0.6209999918937683},{"id":"https://openalex.org/keywords/botulinum-toxin-injection","display_name":"botulinum toxin injection","score":0.7770000100135803},{"id":"https://openalex.org/keywords/behavioral-therapy","display_name":"behavior therapy","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C2778941218","wikidata":"https://www.wikidata.org/wiki/Q331231","display_name":"Overactive bladder","level":3,"score":0.9554030895233154},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.929215133190155},{"id":"https://openalex.org/C3019258254","wikidata":"https://www.wikidata.org/wiki/Q1423317","display_name":"Second line","level":3,"score":0.4453323483467102},{"id":"https://openalex.org/C77411442","wikidata":"https://www.wikidata.org/wiki/Q181100","display_name":"Urinary system","level":2,"score":0.42841649055480957},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4235919117927551},{"id":"https://openalex.org/C2993493390","wikidata":"https://www.wikidata.org/wiki/Q5453208","display_name":"First line","level":2,"score":0.4064539968967438},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.353424072265625},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3477940857410431},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3033060133457184},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29230642318725586},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.1779613494873047},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/01.ju.0000556188.39522.b7","doi":"https://doi.org/10.1097/01.ju.0000556188.39522.b7","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ju.0000556188.39522.b7","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.5,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2940664679","https://openalex.org/W4246243229","https://openalex.org/W4390908891","https://openalex.org/W3014907391","https://openalex.org/W2605284431","https://openalex.org/W4392792787","https://openalex.org/W2952136357","https://openalex.org/W4309931038","https://openalex.org/W4360605557","https://openalex.org/W2792116695"],"abstract_inverted_index":{"You":[0],"have":[1,129,263],"accessJournal":[2],"of":[3,100,155,182,190,199,207,287,354,392,407,412,429,475,480],"UrologyUrodynamics/Lower":[4],"Urinary":[5],"Tract":[6],"Dysfunction/Female":[7],"Pelvic":[8],"Medicine:":[9],"Non-neurogenic":[10],"Voiding":[11],"Dysfunction":[12],"I":[13],"(PD31)1":[14],"Apr":[15],"2019PD31-03":[16],"PROPORTION":[17],"OF":[18],"WOMEN":[19],"WITH":[20],"OVERACTIVE":[21],"BLADDER":[22],"WHO":[23],"PROGRESS":[24],"FROM":[25],"SECOND-":[26],"TO":[27],"THIRD-LINE":[28],"TREATMENT":[29],"IN":[30],"A":[31,203,352],"REAL-WORLD":[32],"SETTING":[33],"Erika":[34,43,514],"Wolff*,":[35],"Thomas":[36,52,521],"Cook,":[37],"Anna":[38,61,528],"Kirby,":[39],"and":[40,70,116,141,214,250,273,317,331,371,491,510],"John":[41,71,535],"Gore":[42,73,536],"Wolff*Erika":[44],"Wolff*":[45,515],"More":[46,55,64,74,516,523,530,537],"articles":[47,56,65,75,517,524,531,538],"by":[48,57,66,76,368,486,505,518,525,532,539],"this":[49,58,67,77,183,456,519,526,533,540],"author":[50,59,68,78,520,527,534,541],",":[51,60,69],"CookThomas":[53],"Cook":[54,522],"KirbyAnna":[62],"Kirby":[63,529],"GoreJohn":[72],"View":[79],"All":[80,232,543],"Author":[81],"Informationhttps://doi.org/10.1097/01.JU.0000556188.39522.b7AboutPDF":[82],"ToolsAdd":[83],"to":[84,151,173,186,272,387,434,442,447],"favoritesDownload":[85],"CitationsTrack":[86],"CitationsPermissionsReprints":[87],"ShareFacebookLinked":[88],"InTwitterEmail":[89],"Abstract":[90],"INTRODUCTION":[91],"AND":[92],"OBJECTIVES:":[93],"Overactive":[94],"bladder":[95],"(OAB)":[96],"affects":[97],"nearly":[98,336],"half":[99],"women.":[101],"Per":[102],"AUA/SUFU":[103],"treatment":[104,120,175,195,219,348,419,474],"guidelines,":[105],"patients":[106,133,166],"should":[107],"be":[108],"offered":[109,454],"first-line":[110],"behavioral":[111],"therapies,":[112],"second-line":[113,217,333,417],"medical":[114,218,334,418],"treatment,":[115,335,389,448],"then":[117],"third-line":[118,174,194,321,347,388,424,435,451],"procedure-based":[119],"(botox":[121],"injections":[122],"or":[123,236,345,449],"neuromodulation)":[124],"if":[125,259],"needed.":[126],"Numerous":[127],"studies":[128],"shown":[130],"that":[131],"most":[132],"diagnosed":[134,210,328],"with":[135,211,329,461,477],"OAB":[136,213,242,330,375,396],"are":[137,144],"not":[138,262,341,440],"prescribed":[139,215,332],"medications":[140,146,408],"those":[142],"who":[143,192,238,297],"discontinue":[145],"within":[147,196,312,349],"one":[148,269],"year":[149,270],"due":[150],"side":[152],"effects,":[153],"lack":[154],"efficacy,":[156],"and/or":[157],"cost.":[158],"However,":[159],"it":[160,438],"remains":[161],"unknown":[162],"how":[163],"frequently":[164],"female":[165],"in":[167,176,455,472],"the":[168,188,223,285,293,313,325,473],"U.S.":[169],"progress":[170],"from":[171,385,432,463],"second-":[172,386,433],"a":[177,216,226,310,320,423,469],"real-world":[178],"setting.":[179],"The":[180,281],"purpose":[181],"study":[184,206],"was":[185,220,284],"determine":[187],"proportion":[189,286],"women":[191,209,233,288,327,357,413,430,476],"undergo":[193],"two":[197,274,290,350,369,379,400],"years":[198,275,291,404],"initiating":[200],"medications.":[201],"METHODS:":[202],"retrospective":[204],"cohort":[205],"adult":[208],"non-neurogenic":[212],"conducted":[221],"using":[222],"Truven":[224],"MarketScan,":[225],"nationally":[227],"representative":[228],"administrative":[229],"claims":[230,377,398,457],"database.":[231],"aged":[234],"63":[235],"less":[237],"had":[239,308,374,395,421],"their":[240,277,301,305,343,359,366],"first":[241,278,294],"medication":[243,376,397],"prescription":[244,279,295,311,344,360,367],"claim":[245,296],"between":[246],"January":[247],"1,":[248],"2013,":[249],"December":[251],"31,":[252],"2014,":[253],"were":[254,257,414,453],"included.":[255],"Women":[256],"excluded":[258],"they":[260],"did":[261,340],"continuous":[264],"enrollment":[265],"for":[266,409],"at":[267,289,361,378,399],"least":[268,362],"prior":[271],"following":[276,292],"claim.":[280],"primary":[282],"outcome":[283],"1)":[298],"never":[299],"refilled":[300,358],"prescription,":[302,306],"2)":[303],"discontinued":[304,365],"3)":[307],"filled":[309],"previous":[314,464],"90":[315],"days,":[316],"4)":[318],"received":[319],"treatment.":[322,425,436],"RESULTS:":[323],"Of":[324],"17,429":[326],"one-third":[337],"(n=5,331,":[338],"30%)":[339],"refill":[342],"receive":[346],"years.":[351,380,401],"total":[353],"6,295":[355],"(36%)":[356],"once":[363],"but":[364],"years,":[370],"4,265":[372],"(24%)":[373],"Only":[381],"1,538":[382],"(9%)":[383],"progressed":[384,431],"383":[390],"(25%)":[391],"whom":[393],"also":[394],"CONCLUSIONS:":[402],"Two":[403],"after":[405],"initiation":[406],"OAB,":[410],"two-thirds":[411],"neither":[415],"on":[416],"nor":[420],"undergone":[422],"Less":[426],"than":[427],"10%":[428],"While":[437],"is":[439],"possible":[441],"assess":[443],"symptom":[444],"severity,":[445],"response":[446],"whether":[450],"treatments":[452],"database,":[458],"when":[459],"combined":[460],"findings":[462],"studies,":[465],"these":[466],"results":[467],"highlight":[468],"potential":[470],"gap":[471],"OAB.":[478],"Source":[479],"Funding:":[481],"None":[482],"Seattle,":[483],"WA\u00a9":[484],"2019":[485,504],"American":[487,506],"Urological":[488,507],"Association":[489,508],"Education":[490,509],"Research,":[492,511],"Inc.FiguresReferencesRelatedDetails":[493],"Volume":[494],"201Issue":[495],"Supplement":[496],"4April":[497],"2019Page:":[498],"e566-e566":[499],"Advertisement":[500,544],"Copyright":[501],"&":[502],"Permissions\u00a9":[503],"Inc.MetricsAuthor":[512],"Information":[513],"Expand":[542],"PDF":[545],"downloadLoading":[546],"...":[547]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2019-05-03T00:00:00"}